Ongoing research is exploring: Combination Therapies: Investigating the potential of combining GLP-1 agonists with other medications (such as GIP receptor agonists) to achieve even greater weight loss and metabolic benefits
People who pair the drug with a structured nutrition approach and resistance training lose more weight and preserve more muscle mass
ARDs, which include rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and axial spondyloarthritis, are characterised with chronic systemic inflammation that accelerates atherogenesis and substantially increases premature cardiovascular death
Future research should identify strategies to mitigate pregnancy-related weight gain in people who stop GLP-1s for pregnancy, Maya said
First, the retrospective design limits causal inference
One such metabolite that has attracted considerable interest is TMAO